The new company that is going to take over major drugmaker Pharmstandard's over-the-counter business will assume the name OTCpharm, a news report said Thursday.
OTC stands for over the counter.
The new legal entity will have a share capital of 15 million rubles and will be split into 151 million shares, of which nearly 38 million will belong to Pharmstandard, Vedomosti reported.
The report cited information from the materials that the company is preparing for its shareholder meeting Sept. 27.
Historically, over-the-counter sales have driven the company's growth. But now its sales under state contracts constitute more than half of the total business.
Over-the-counter sales have a less transparent business model, which puts pressure on the value, said Igor Krylov, the company's chief. That is why the company announced in July it wanted to spin off the business, he said.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.
